XALKORI: payments to doctors
Payments that named XALKORI as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $614K
- Providers
- 5,333
- Transactions
- 14,513
- Average per transaction
- $42
The per-transaction average — $42 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,333 providers the average total is $115, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pfizer | $476,365 | 77.6% |
| Array Biopharma Inc | $136,768 | 22.3% |
| Pfizer Pharmaceuticals LLC | $489 | 0.1% |
| PBG Puerto RICO LLC | $314 | 0.1% |
| EMD Serono, Inc. | $12 | 0.0% |